Developmental regulation of phospholipid secretion by fetal type II pneumocytes
- 5 January 1996
- journal article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
- Vol. 1299 (1), 39-46
- https://doi.org/10.1016/0005-2760(95)00186-7
Abstract
Surfactant sufficiency is dependent upon adequate synthesis and secretion of surfactant by the type II alveolar epithelium. Our laboratory has previously shown that basal secretion of surfactant phospholipid by differentiated fetal type II cells is lower than the basal secretion by adult cells. The purposes of this study were to determine if undifferentiated fetal type II cells can secrete phosphatidylcholine, to determine if terbutaline, a β-adrenergic agonist, stimulates secretion of surfactant phospholipids by undifferentiated fetal cells and to examine the effects of differentiation on secretion of surfactant phospholipids by fetal cells. Constitutive (basal) secretion of phosphatidylcholine increased linearly as a function of time in both undifferentiated and differentiated cells, but the rate of secretion was greater in differentiated cells than the rate of secretion in undifferentiated cells. Terbutaline caused a concentration-dependent increase in secretion in both undifferentiated and differentiated cells. Maximal effective concentration and EC50 were similar for undifferentiated (10−6 M, 0.2 μM) and differentiated (10−5 M, 0.3 μM) cells. The relative stimulation of secretion above control values was greater for undifferentiated cells. The kinetics of terbutaline stimulation varied significantly with cellular differentiation. Terbutaline resulted in 230% stimulation of secretion in undifferentiated cells at 30 min followed by a decline in the response to terbutaline at 60 to 120 min. In contrast, terbutaline stimulated secretion by differentiated cells showed a sustained linear increase from 0 to 120 min. This regulation of stimulated secretion is not present in undifferentiated cells. We conclude that undifferentiated type II cells are capable of the secretion of phosphatidylcholine and that terbutaline stimulates secretion by undifferentiated cells. Furthermore, basal secretion increases as a function of differentiation of type II cells and the regulation of stimulated secretion seen in differentiated cells is not developed in undifferentiated cells. The developmental regulation of the secretion of surfactant is complex and probably involves both excitatory as well as inhibitory mechanisms which develop at different stages of differentiation of the type II cell.Keywords
This publication has 19 references indexed in Scilit:
- Functional evidence for involvement of P2 purinoceptors in the ATP stimulation of phosphatidylcholine secretion in type II alveolar epithelial cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Surfactant for the Treatment of Respiratory Distress SyndromeAmerican Review of Respiratory Disease, 1987
- Culture of differentiated and undifferentiated type II cells from fetal rat lungBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1987
- P2Y‐purinoceptor regulation of surfactant secretion from rat isolated alveolar type II cells is associated with mobilization of intracellular calciumBritish Journal of Pharmacology, 1987
- Purinoceptor agonists stimulate phosphatidylcholine secretion in primary cultures of adult rat type II pneumocytesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Arachidonic acid metabolites stimulate phosphatidylcholine secretion in primary cultures of type II pneumocytesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985
- Secretion of surfactant by primary cultures of alveolar type II cells isolated from ratsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1982
- ARTIFICIAL SURFACTANT THERAPY IN HYALINE-MEMBRANE DISEASEThe Lancet, 1980
- Pulmonary Alveolar Type II Cells Isolated from RatsJCI Insight, 1979
- Stimulation of Secretion of Disaturated Phosphatidylcholine from Isolated Alveolar Type II Cells by 12-O-Tetradecanoyl-13-Phorbol Acetate1,2American Review of Respiratory Disease, 1978